A 2021 phase 2 trial published in The New England Journal of Medicine showed semaglutide 2.4 mg achieved NASH resolution without worsening fibrosis in 59% of patients versus 17% on placebo (Newsome et al., NEJM 2021)
A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge in reducing blood sugar and weight
People with serious gastrointestinal conditions, like gastroparesis or uncontrolled inflammatory bowel disease, should not take GLP-1 medications
call Today and speak to a Licensed medical Provider 631-314-8949 Liraglutide Liraglutide is a highly effective weight-loss medication that reduces hunger, increases satiety, and boosts insulin release
She also took home, oh, six Grammy awards, sweeping every category she was nominated in